A Single Injection of Recombinant Measles Virus Vaccines Expressing Human Immunodeficiency Virus (HIV) Type 1 Clade B Envelope Glycoproteins Induces Neutralizing Antibodies and Cellular Immune Responses to HIV
Open Access
- 1 January 2004
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (1) , 146-157
Abstract
The anchored and secreted forms of the human immunodeficiency virus type 1 (HIV-1) 89.6 envelope glycoprotein, either complete or after deletion of the V3 loop, were expressed in a cloned attenuated measles virus (MV) vector. The recombinant viruses grew as efficiently as the parental virus and expressed high levels of the HIV protein. Expression was stable during serial passages. The immunogenicity of these recombinant vectors was tested in mice susceptible to MV and in macaques. High titers of antibodies to both MV and HIV-Env were obtained after a single injection in susceptible mice. These antibodies neutralized homologous SHIV89.6p virus, as well as several heterologous HIV-1 primary isolates. A gp160 mutant in which the V3 loop was deleted induced antibodies that neutralized heterologous viruses more efficiently than antibodies induced by the native envelope protein. A high level of CD8 + and CD4 + cells specific for HIV gp120 was also detected in MV-susceptible mice. Furthermore, recombinant MV was able to raise immune responses against HIV in mice and macaques with a preexisting anti-MV immunity. Therefore, recombinant MV vaccines inducing anti-HIV neutralizing antibodies and specific T lymphocytes responses deserve to be tested as a candidate AIDS vaccine.Keywords
This publication has 83 references indexed in Scilit:
- Effect of the V3 Loop Deletion of Envelope Glycoprotein on Cellular Responses and Protection against Challenge with Recombinant Vaccinia Virus Expressing gp160 of Primary Human Immunodeficiency Virus Type 1 IsolatesJournal of Virology, 2002
- The Danger Model: A Renewed Sense of SelfScience, 2002
- Protection against Simian Immunodeficiency Virus Vaginal Challenge by Using Sabin Poliovirus VectorsJournal of Virology, 2001
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- MHC Class I–Restricted CTL Responses to Exogenous AntigensImmunity, 1996
- Antibody neutralization of HIV-1Immunology Today, 1996
- A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejectionGenes to Cells, 1996
- HIV-1 Reverse Transcription A Termination Step at the Center of the GenomeJournal of Molecular Biology, 1994
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedeberg's Archives of Pharmacology, 1931